
Keywords: 5HIAA; 5-hydroxyindolacetic acid; α-AASA; α-aminoadipic semialdehyde; ABAS II; Adaptive Behavioral Assessment System-II; AIMS; Alberta Infant Motor Score; CSF; cerebral spinal fluid; DOL; days of life; EEG; electroencephalography; FMOC; fluorenylmethoxy